Cargando…

Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD

Background: Optic neuritis (ON) is an important clinical manifestation of neuromyelitis optic spectrum disease (NMOSD). Myelin oligodendrocyte glycoprotein (MOG) antibody-related and aquaporin 4 (AQP4) antibody-related ON show different disease patterns. The aim of this study was to explore the diff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Chenyang, Zhuo, Zhizheng, Duan, Yunyun, Yao, Yajun, Su, Lei, Zhang, Xinghu, Song, Tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220215/ https://www.ncbi.nlm.nih.gov/pubmed/34177778 http://dx.doi.org/10.3389/fneur.2021.673472

Ejemplares similares

Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS
por: Duan, Yunyun, et al.
Publicado: (2021)

Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody
por: Takano, Shunichiro, et al.
Publicado: (2019)

A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies
por: Zhou, Lin, et al.
Publicado: (2022)

Microstructural visual system changes in AQP4-antibody–seropositive NMOSD
por: Oertel, Frederike C., et al.
Publicado: (2017)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
por: Bollo, Luca, et al.
Publicado: (2021)

Rapid Administration of High-Dose Intravenous Methylprednisolone Improves Visual Outcomes After Optic Neuritis in Patients With AQP4-IgG-Positive NMOSD
por: Akaishi, Tetsuya, et al.
Publicado: (2020)

AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis
por: Filippatou, Angeliki G., et al.
Publicado: (2020)

The use of OCT in good visual acuity MOGAD and AQP4-NMOSD patients; with and without optic neuritis
por: Roca-Fernández, A, et al.
Publicado: (2021)

Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis
por: Messina, Silvia, et al.
Publicado: (2021)

Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation
por: Khalilidehkordi, Elham, et al.
Publicado: (2020)

Contemporary management challenges in seropositive NMOSD
por: Costello, Fiona, et al.
Publicado: (2022)

A case report of neurosyphilis coexisting with a positive MOG antibody manifested as optic neuritis
por: Shi, Min, et al.
Publicado: (2023)

AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD
por: Prain, Kerri, et al.
Publicado: (2019)

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients
por: Pache, Florence, et al.
Publicado: (2016)

Uveitis, optic neuritis and MOG
por: Gupta, Pranjal, et al.
Publicado: (2020)

Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies
por: Hyun, Jae-Won, et al.
Publicado: (2020)

Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection
por: Sun, Chuan-bin
Publicado: (2023)

Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
por: Stiebel-Kalish, Hadas, et al.
Publicado: (2019)

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
por: Schmidt, Felix A., et al.
Publicado: (2020)

Association of aquaporin-4 antibody-seropositive optic neuritis with vision-related quality of life and depression
por: Song, Ruitong, et al.
Publicado: (2023)

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
por: Brill, Livnat, et al.
Publicado: (2021)

Chronic Cognitive Impairment in AQP4+ NMOSD With Improvement in Cognition on Eculizumab: A Report of Two Cases
por: Saab, Georges, et al.
Publicado: (2022)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison
por: Narongkhananukul, Chanomporn, et al.
Publicado: (2020)

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis
por: Mori, Sotaro, et al.
Publicado: (2020)

New Onset Visual Loss in MOG Antibody Disease: Optic Neuritis or Central Serous Retinopathy?
por: James, Joe, et al.
Publicado: (2022)

Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
por: Chen, Xuelian, et al.
Publicado: (2023)

Corrigendum: Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
por: Chen, Xuelian, et al.
Publicado: (2023)

Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD
por: Fadda, Giulia, et al.
Publicado: (2022)

Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD
por: Yan, Yaping, et al.
Publicado: (2016)

Prognostic Factors for Visual Outcomes Following the First Episode of NMOSD-Related Optic Neuritis in Affected Eyes
por: Thongmee, Watcharaporn, et al.
Publicado: (2020)

Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis
por: Chalmoukou, Konstantina, et al.
Publicado: (2015)

Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD
por: Schroeder-Castagno, Maria, et al.
Publicado: (2022)

Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD
por: Masuda, Hiroki, et al.
Publicado: (2023)

Low Contrast Visual Evoked Potentials for Early Detection of Optic Neuritis
por: Park, Soo-Hyun, et al.
Publicado: (2022)

Early predictors of visual and axonal outcomes after acute optic neuritis
por: Nguyen, Minh N. L., et al.
Publicado: (2022)

Factors influencing intravenous methylprednisolone pulse therapy in Chinese patients with isolated optic neuritis associated with AQP4 antibody-seropositive neuromyelitis optica
por: Guo, Sitong, et al.
Publicado: (2021)

Optic neuritis of MOG-IgG-associated autoimmune disorders: a case report
por: Li, Tiantian, et al.
Publicado: (2021)

Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series
por: Nurul-Ain, Masnon, et al.
Publicado: (2021)

Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort
por: Dauby, Solène, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7oan8l940bm1di3bsuee9m7hvm